|
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a |
90.00% |
|
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. |
90.00% |
|
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potent |
90.00% |
|
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. |
90.00% |
|
The present state of antineoplaston research (1) |
90.00% |
|
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice |
90.00% |
|
Effects of CANELIM capsule drug-contained serum on viscoelasticity |
90.00% |
|
The use of mushroom glucans and proteoglycans in cancer treatment. |
90.00% |
|
Medicinal plants and cancer chemoprevention. |
90.00% |
|
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced |
90.00% |
|
Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, |
90.00% |
|
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications |
90.00% |
|
Why are tumour blood vessels abnormal and why is it important to know? |
90.00% |
|
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study. |
90.00% |
|
Metronomic schedule of temozolomide with conventional dose of cisplatin in metastatic melanoma. Sub-category: Melanoma Categor |
90.00% |
|
Why We Get Sick And How to Get Well |
90.00% |
|
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer. |
90.00% |
|
Is it time to test metformin in breast cancer clinical trials? |
90.00% |
|
Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. |
90.00% |
|
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. |
90.00% |
|
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors |
90.00% |
|
Chemotherapy of advanced epithelial cancer--a critical review |
90.00% |
|
MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. |
90.00% |
|
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. |
90.00% |
|
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. |
90.00% |
|
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. |
90.00% |
|
Mistletoe therapy in oncology |
90.00% |
|
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. |
90.00% |
|
Metronomic chemotherapy: changing the paradigm that more is better. |
90.00% |
|
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside. |
90.00% |
|
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ |
90.00% |
|
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. |
90.00% |
|
Low dose "Metronomic" Chemotherapy |
89.00% |
|
GcMAF-The cancer revolution from Japan |
87.50% |
|
Systems biology: a therapeutic target for tumor therapy. |
86.67% |
|
Todoxin, the immune stimulant from Serbia |
86.36% |
|
82 year old man with prostate cancer |
85.00% |
|
Curcumin |
85.00% |
|
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. |
85.00% |
|
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial |
85.00% |
|
The anti-angiogenic basis of metronomic chemotherapy. |
85.00% |
|
Adjuvant vaccination with melanoma antigen pulsed dendritic cells (DCs) in stage III melanoma patients. |
85.00% |
|
Hypericine |
83.33% |
|
Mistletoe Therapy in Cancer |
83.33% |
|
Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast ca |
80.00% |
|
Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human.... |
80.00% |
|
In vitro screening for the tumoricidal properties of international medicinal herbs |
80.00% |
|
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory |
80.00% |
|
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. |
80.00% |
|
Treatment of locally advanced pancreatic cancer with concurrent uftoral and radiotherapy. Results from 64 patients treated from |
80.00% |
|
Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins |
80.00% |
|
Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain |
80.00% |
|
Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regi |
80.00% |
|
Response of brain metastases from breast cancer to megestrol acetate: a case report. |
80.00% |
|
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. |
80.00% |
|
N-acetylcysteine inhibits proliferation, adhesion, migration and invasion of human bladder cancer cells. |
80.00% |
|
The emerging low-dose therapy for advanced cancers. |
80.00% |
|
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission |
80.00% |
|
Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen |
80.00% |
|
ROS production and angiogenic regulation by macrophages in response to heat therapy. |
80.00% |
|
Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual sta |
80.00% |
|
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy – case report and review of literat |
80.00% |
|
Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their de |
80.00% |
|
An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis. |
80.00% |
|
Outside the box--novel therapeutic strategies for glioblastoma. |
80.00% |
|
Antinociceptive effect of ten day administration of Ukrain in mice and interaction of the treatment with morphine |
80.00% |
|
Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. |
80.00% |
|
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. |
80.00% |
|
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo. |
80.00% |
|
Coronavirus could cause 35,000 extra UK cancer deaths, experts warn |
80.00% |
|
Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto |
80.00% |
|
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in--- |
80.00% |
|
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high... |
80.00% |
|
Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro |
80.00% |
|
A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort |
80.00% |
|
Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. |
80.00% |
|
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refract |
80.00% |
|
Different metronomic treatment schedules |
80.00% |
|
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside. |
80.00% |
|
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m |
80.00% |
|
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. |
80.00% |
|
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort |
80.00% |
|
The way ‘Covid deaths’ are being counted is a national scandal |
80.00% |
|
Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthe.... |
80.00% |
|
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytot..... |
80.00% |
|
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell c |
80.00% |
|
Attitudes of patients to alternative medicine for cancer treatment. |
80.00% |
|
Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. |
80.00% |
|
Ukrain: Debated Subjects |
80.00% |
|
Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. |
80.00% |
|
A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation |
80.00% |
|
Alternative Cancer Treatment (interview with Dr. Gonzalez by Dr. Mercola) |
80.00% |
|
Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells |
80.00% |
|
How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. |
80.00% |
|
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. |
80.00% |
|
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer |
80.00% |
|
A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer. Yorkshire GI Tumour Group. |
80.00% |
|
Anthroposophic health care--different and home-like. |
80.00% |
|
Resveratrol |
80.00% |
|
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer. |
80.00% |
